This page provides links to every currently open campaign*, letting you view industry calls for opportunities and requests for proposals. Click on the links to see a full pdf overview of what these companies are looking for. You can use this page to share details on these campaigns with colleagues and researchers at your institute, even if they haven't registered for an Inpart account yet.
Seeking Innovative Late-stage Hospital Assets for Paediatric Diseases - Shionogi Europe
Closes 28th October 2024
Seeking Biomarker-guided Approaches for the Diagnosis of Dementia - Nissan Chemical Corporation
Closes 28th October 2024
Novel Therapeutics for Common Skin Conditions - STADA Thornton and Ross
Closes 28th October 2024
Seeking Technologies for Sensing Analytes in Blood - A leading company in the cardiac surgery space
Closes 21st October 2024
Predictive in vitro Assays for Kidney Retention by Radioconjugates - AstraZeneca
Closes 21st October 2024
Seeking Novel Targeted Approaches for Genetic Kidney Disease - a world leader in developing treatments for rare genetic diseases
Closes 14th October 2024
Therapeutic Strategies to Address TDP-43 Pathology in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia - a global leader in the creation and commercialization of pioneering therapies for rare genetic diseases
Closes 14th October 2024
Home Fragrance Delivery, Noticeability and Modelling in the Air - Reckitt
Closes 7th October 2024
Novel Strategies for Targeted Drug Delivery to CNS, Bone, Cartilage, Skeletal Muscle and Kidney Tissues - a world leader in therapies for rare genetic diseases
Closes 30th September 2024
Seeking Transformational Therapeutic Approaches for Sickle Cell Disease and Beta-thalassemia - a global leader in the rare disease space
Closes 30th September 2024
For advice on writing a more engaging response to a campaign, view our advice page here. Once you're ready to respond, log into Inpart or register for a new account to submit through our website.
*Campaigns with geographic restrictions may not be shown here